Drug Shortage Report for ANAPROX
| Report ID | 232627 |
| Drug Identification Number | 02162725 |
| Brand name | ANAPROX |
| Common or Proper name | Naproxen sodium tablets USP |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN SODIUM |
| Strength(s) | 275MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-07-25 |
| Estimated end date | 2024-12-25 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-07-26 |
| Company comments | Delays by manufacturer |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-07-26 | English | Compare |
| v6 | 2024-07-10 | French | Compare |
| v5 | 2024-07-10 | English | Compare |
| v4 | 2024-07-10 | French | Compare |
| v3 | 2024-07-10 | English | Compare |
| v2 | 2024-07-10 | French | Compare |
| v1 | 2024-07-10 | English | Compare |
Showing 1 to 7 of 7